Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure
暂无分享,去创建一个
P. Doevendans | J. Sluijter | M. Huibers | J. Laman | A. Vink | S. D. de Jager | E. Mol | P. van den Hoogen | A. Schoneveld